CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464670809
- Phone
- (650) 900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $50,475
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 24 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-10 | Mitchell Edith P. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-07-08 | Novo Holdings A/S 10% owner | Sale | −741,440 | $5.37 | $4.0M | 1,389,498 |
| 2020-07-07 | Novo Holdings A/S 10% owner | Sale | −796,622 | $5.25 | $4.2M | 2,130,938 |
| 2020-06-09 | ADAMS STREET PARTNERS LLC 10% owner | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-09 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-09 | Morrison Scott W Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-09 | Krognes Steve E. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-09 | Gould Terry P Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-09 | Grais Linda S Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-09 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-03-19 | Grais Linda S Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-03-19 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-03-19 | Krognes Steve E. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-03-19 | Morrison Scott W Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-03-19 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-03-19 | Gould Terry P Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-03-19 | ADAMS STREET PARTNERS LLC 10% owner | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-12-12 | Verner Erik J. VP, Chemistry Research | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-12-12 | Mobasher Mehrdad VP, Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-12-12 | MILLER RICHARD A MD President and CEO | Grant or award · Stock Option (Right to Buy) | +320,000 | 320,000 |
Page 9 of 15 · 286 trades